Implantable cardioverter-defibrillator-related procedures and associated complications in continuous flow left

Ashwin Ravichandran1, Naga Venkata K Pothineni2, Jaimin R Trivedi3

  • 1St. Vincent Heart Center, Indianapolis, Indiana.

Heart Rhythm O2
|January 6, 2022
PubMed

Insights

Procedures for implantable cardioverter-defibrillators (ICD) and cardiac resynchronization therapy devices (CRT-D) are frequent in left ventricular assist device (LVAD) patients. Continued CRT-D use post-LVAD increases generator changes but does not impact long-term survival.

Area of Science:

  • Cardiology
  • Medical Devices
  • Heart Failure Management

Background:

  • Limited data exist on complication rates for implantable cardioverter-defibrillators (ICD) and cardiac resynchronization therapy devices (CRT-D) in patients with left ventricular assist devices (LVAD).
  • Understanding these complication rates is crucial for managing patients with advanced heart failure.

Purpose of the Study:

  • To describe the incidence and characteristics of ICD and CRT-D related procedures and complications in a multicenter LVAD cohort.
  • To analyze device type, therapies, procedural complications, and long-term survival in LVAD patients with pre-existing ICDs or CRT-Ds.

Main Methods:

  • A multicenter cohort study included 537 LVAD patients with pre-existing ICD or CRT-D.
  • Data collected included device type, device therapies, procedural complications, and long-term survival.
  • Statistical analysis was performed to compare outcomes between CRT-D and ICD-only groups.

Main Results:

  • Of 537 patients, 280 had CRT-D and 257 had ICD only.
  • Generator replacement was significantly higher in the CRT-D group (28.2% vs 18.3%).
  • Device-related complications occurred in 13% of CRT-D patients and 8% of ICD patients (P = .06), with similar rates of pocket hematoma, infection, and lead malfunction. Post-LVAD antitachycardia pacing for ventricular arrhythmias was higher in the CRT-D group (35% vs 26%).

Conclusions:

  • Cardiac implantable electronic device procedures are common in LVAD patients.
  • Continued CRT-D therapy post-LVAD is associated with significantly more generator changes and a trend towards higher device/lead complications.
  • Device-related complications did not impact long-term survival.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
60
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
256
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
229
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
50
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
252
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
60